News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hiba Al-Tarrah: Day 1 – SIOP Asia 2025 was a complete success
Hiba Al-Tarrah/LinkedIn
Apr 14, 2025, 13:47

Hiba Al-Tarrah: Day 1 – SIOP Asia 2025 was a complete success

Hiba Al-Tarrah, Pediatric Hematology/Oncology Fellowship Program Director at King Fahad Specialist Hospital Dammam, shared a post on LinkedIn:

“Day 1 SIOP Asia 2025 was a complete success. We were honored to host H.R.H Adela Bint Abdullah.

Welcome to Riyadh every one.”

Hiba Al-Tarrah: Day 1 - SIOP Asia 2025 was a complete success

Don’t miss SIOP Asia 2025 related post on OncoDaily.

cancer Hiba Al-Tarrah OncoDaily Oncology Riyadh SIOPAsia2025
Special Coverage
Voices
Aug 21, 2025, 14:26
Chrystal Paulos: Exciting Opportunities to Build with the Paulos Lab at Winship Cancer Institute
Voices
Aug 21, 2025, 14:21
Caryn Lerman: HPV16 Causes More Than Half of Cervical Cancer Cases
Voices
Aug 21, 2025, 14:18
Svetlana Nikic: Changing the Game in Precision Oncology Education
Voices
Aug 21, 2025, 14:07
NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial
Voices
Aug 21, 2025, 14:06
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute is Expanding its Clinical Research Team
Voices
Aug 21, 2025, 14:01
IU Simon Cancer Center Engages 1,800 Fairgoers at Indiana State Fair
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center